COSMOS Pharmaceutical Corporation (3349.T)
JPY 6521.0
(-1.63%)
JPY 6521.0
(-1.63%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 55.17 Billion | 54.43 Billion | 32.19 Billion | 27.87 Billion | 65.46 Billion | 34.37 Billion |
| Net Income | 24.45 Billion | 32.77 Billion | 33.04 Billion | 38.59 Billion | 30.4 Billion | 27.13 Billion |
| Depreciation & Amortization | 19.92 Billion | 17.36 Billion | 15.11 Billion | 13.78 Billion | 13.56 Billion | 12.95 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 9.66 Billion | 10.16 Billion | -1.2 Billion | -10.93 Billion | 25.77 Billion | 255 Million |
| Other non-cash items | 33.81 Billion | -5.87 Billion | -14.76 Billion | -13.57 Billion | -4.27 Billion | -5.97 Billion |
| Investing Cash Flow | -57.32 Billion | -49.11 Billion | -43.71 Billion | -19.38 Billion | -26.95 Billion | -30.04 Billion |
| Investments in PPE | -55.81 Billion | -46.63 Billion | -43.49 Billion | -26.06 Billion | -25.94 Billion | -29.04 Billion |
| Acquisitions | 718 Million | 46 Million | 1.51 Billion | 8.67 Billion | -184 Million | 412 Million |
| Investment purchases | -523 Million | -500 Million | -713 Million | -597 Million | -214 Million | -398 Million |
| Sales/Maturities of investments | 431 Million | 428 Million | 407 Million | 417 Million | 398 Million | 400 Million |
| Other Investing Activities | -2.14 Billion | -2.45 Billion | -1.43 Billion | -1.81 Billion | -1 Billion | -1.41 Billion |
| Financing Cash Flow | 8.52 Billion | 3.24 Billion | -6.22 Billion | -5.5 Billion | -5.4 Billion | -6.98 Billion |
| Debt repayment | -13.18 Billion | -1.62 Billion | -1.48 Billion | -1.48 Billion | -1.48 Billion | -3.19 Billion |
| Dividends payments | -4.65 Billion | -3.26 Billion | -3.26 Billion | -2.27 Billion | -2.07 Billion | -1.78 Billion |
| Common Stock Repurchased | - | -2 Million | -2 Million | - | - | - |
| Common Stock Issuance | - | 8.14 Billion | -1.46 Billion | - | - | - |
| Other Financing Activities | -1 Million | -3 Million | -2 Million | -1.74 Billion | -1.84 Billion | -2 Billion |
| Accounts receivables | -1.82 Billion | -254 Million | -97 Million | 8 Million | 289 Million | -306 Million |
| Accounts payables | 17.69 Billion | 22.62 Billion | 6.18 Billion | -3.49 Billion | 25.73 Billion | 5.73 Billion |
| Inventory | -8.7 Billion | -11.15 Billion | -5.85 Billion | -7 Billion | -295 Million | -4.72 Billion |
| Other working capital | 2.5 Billion | -1.05 Billion | -1.43 Billion | -445 Million | 46 Million | -448 Million |
| Cash at beginning of period | 45.92 Billion | 37.36 Billion | 55.1 Billion | 52.12 Billion | 19.02 Billion | 21.66 Billion |
| Cash at end of period | 52.3 Billion | 45.92 Billion | 37.36 Billion | 55.1 Billion | 52.12 Billion | 19.02 Billion |
| Capital Expenditure | -55.81 Billion | -46.63 Billion | -43.49 Billion | -26.06 Billion | -25.94 Billion | -29.04 Billion |
| Effect of forex changes on cash | - | - | -1 Million | -1 Million | - | -1 Million |
| Net cash flow / Change in cash | 6.37 Billion | 8.56 Billion | -17.74 Billion | 2.98 Billion | 33.1 Billion | -2.64 Billion |
| Free Cash Flow | -635 Million | 7.79 Billion | -11.3 Billion | 1.81 Billion | 39.51 Billion | 5.33 Billion |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.09 Billion | 24.45 Billion | 5.77 Billion | 5.07 Billion | 6.5 Billion | 32.77 Billion |
| Depreciation & Amortization | - | 19.92 Billion | - | 4.82 Billion | 4.58 Billion | 17.36 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 9.66 Billion | - | - | - | 10.16 Billion |
| Other non-cash items | -7.09 Billion | 33.81 Billion | -5.77 Billion | -5.07 Billion | -6.5 Billion | -5.87 Billion |
| Investing Cash Flow | - | -57.32 Billion | - | - | - | -49.11 Billion |
| Investments in PPE | - | -55.81 Billion | - | - | - | -46.63 Billion |
| Acquisitions | - | 718 Million | - | - | - | 46 Million |
| Investment purchases | - | -523 Million | - | - | - | -500 Million |
| Sales/Maturities of investments | - | 431 Million | - | - | - | 428 Million |
| Other Investing Activities | - | -2.14 Billion | - | - | - | -2.45 Billion |
| Financing Cash Flow | - | 8.52 Billion | - | - | - | 3.24 Billion |
| Debt repayment | - | -13.18 Billion | - | - | - | -1.62 Billion |
| Dividends payments | - | -4.65 Billion | - | - | - | -3.26 Billion |
| Common Stock Repurchased | - | - | - | - | - | -2 Million |
| Common Stock Issuance | - | - | - | - | - | 8.14 Billion |
| Other Financing Activities | - | -1 Million | - | - | - | -3 Million |
| Accounts receivables | - | -1.82 Billion | - | - | - | -254 Million |
| Accounts payables | - | 17.69 Billion | - | - | - | 22.62 Billion |
| Inventory | - | -8.7 Billion | - | - | - | -11.15 Billion |
| Other working capital | - | 2.5 Billion | - | - | - | -1.05 Billion |
| Cash at beginning of period | - | 45.92 Billion | - | 45.91 Billion | 45.92 Billion | 37.36 Billion |
| Cash at end of period | - | 52.3 Billion | - | 29.69 Billion | 45.91 Billion | 45.92 Billion |
| Capital Expenditure | - | -55.81 Billion | - | - | - | -46.63 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 6.37 Billion | - | -16.22 Billion | -12 Million | 8.56 Billion |
| Free Cash Flow | - | -635 Million | - | 9.64 Billion | 9.17 Billion | 7.79 Billion |
CASE
7044
PANCARBON
600731
RIDDHICORP
SGD